Idexx Laboratories (IDXX) Non-Current Debt (2009 - 2026)

Idexx Laboratories has reported Non-Current Debt for 18 years, with the latest figure at $299.9 million in Q2 2026.

• On a quarterly basis, Non-Current Debt fell 33.34% year-over-year to $299.9 million in Q2 2026; TTM through Jun 2026 was $299.9 million, a 33.34% decrease from a year earlier, with the FY2025 full-year figure at $374.8 million, down 16.66% from the prior year.
• Non-Current Debt was $299.9 million for Q2 2026 at Idexx Laboratories, roughly flat from $299.9 million in the prior quarter.
• The five-year high for Non-Current Debt was $773.4 million in Q1 2022, with the low at $299.9 million in Q1 2026.
• Average Non-Current Debt over 5 years is $555.6 million, with a median of $571.8 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Non-Current Debt retreated 0.69% in 2022, then sank 33.34% in 2026.
• Over 5 years, Non-Current Debt stood at $694.4 million in 2022, then slipped by 10.3% to $622.9 million in 2023, then dropped by 27.79% to $449.8 million in 2024, then declined by 16.66% to $374.8 million in 2025, then retreated by 20.0% to $299.9 million in 2026.
• The last three Non-Current Debt figures came in at $299.9 million (Q2 2026), $299.9 million (Q1 2026), and $374.8 million (Q4 2025), per Business Quant data.